• 1. Cavanagh J, Geisler MW. Mood effects on the ERP processing of emotional intensity in faces: a P3 investigation with depressed students. Int J Psychophysiol. 2006;60(1):27—33.
  • 2. Amin HU, Malik AS, Kamel N, Hussain M. A novel approach based on data redundancy for feature extraction of EEG signals. Brain Topogr. 2016;29(2):207—217.
  • 3. Amin HU, Malik AS, Ahmad RF, et al. Feature extraction and classification for EEG signals using wavelet transform and machine learning techniques. Australas Phys Eng Sci

Med. 2015;38(1):139—149.

  • 4. Merikangas KR, Ames M, Cui L, et al. The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry. 2007;64(10):1180-1188.
  • 5. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465-1475.
  • 6. Simon GE, Khandker RK, Ichikawa L, Operskalski BH. Recovery from depression predicts lower health services costs.J Clin Psychiatry. 2006;67(8):1226-1231.
  • 7. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical

practice. Am J Psychiatry. 2006;163(1):28-40.

8. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression.J Consult Clin Psychol. 1989;57(3):414.

  • 9. Gaffan E, Tsaousis J, Kemp-Wheeler S. Researcher allegiance and meta-analysis: the case of cognitive therapy for depression.J Consult Clin Psychol. 1995;63(6):966.
  • 10. Blackburn I, Moore R. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry. 1997;171(4):328-334.
  • 11. Gloaguen V, Cottraux J, Cucherat M, Blackburn I-M. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998;49(1):59—72.
  • 12. Hamilton KE, Dobson KS. Cognitive therapy of depression: pretreatment patient predictors of outcome. Clin Psychol Rev. 2002;22(6):875—893.
  • 13. Weissman MM, Markowitz JC. Interpersonal Psychotherapy of Depression. Jason Aronson, Incorporated; 1994.
  • 14. Collins JF, Elkin I, Sotsky SM, Docherty JP. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J

Psychiatry. 1990;147:711-718.

  • 15. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry. 1994;164(6):759-769.
  • 16. Hardy GE, Barkham M, Shapiro DA, Reynolds S, Rees A, Stiles WB. Credibility and outcome of cognitive—behavioural and psychodynamic—interpersonal psychotherapy. Br J Clin Psychol. 1995;34(4):555-569.
  • 17. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 1997;54(11):1009-1015.
  • 18. Zisook S, Braff DL, Click MA. Monoamine oxidase inhibitors in the treatment of atypical depression. J Clin Psychopharmacol. 1985;5(3):131-137.
  • 19. Anderson I, Tomenson B. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ. 1995;310(6992):1433-1438.
  • 20. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58(1):19-36.
  • 21. MacGillivray S, Arroll B, Hatcher S, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ. 2003;326(7397):1014.
  • 22. Trindade E, Menon D, Topfer L-A, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Can Med Assoc J. 1998;159(10):1245-1252.
  • 23. Mumtaz W, Malik AS, Yasin MAM, Xia L. Review on EEG and ERP predictive biomarkers for major depressive disorder. Biomed Signal Process Control. 2015;22:85-98.
  • 24. Mumtaz W, Xia L, Ali SSA, Yasin MAM, Hussain M, Malik AS. Electroencephalogram (EEG)-based computer-aided technique to diagnose major depressive disorder (MDD). Biomed Signal Process Control. 2017;31:108-115.
  • 25. Yusoff N, Low WY, Yip C-H. Psychometric properties of the Malay Version of the hospital anxiety and depression scale: a study of husbands of breast cancer patients in Kuala Lumpur, Malaysia. Asian PacJ Cancer Prevent. 2011;12(4):915-917.
  • 26. Mahmud WMRW, Awang A, Herman I, Mohamed MN. Analysis of the psychometric properties of the Malay version of Beck Depression Inventory II (BDI-II) among postpartum women in Kedah, north west of peninsular Malaysia. Malays J Med Sci MJMS. 2004;11(2):19.
  • 27. Fosgate GT. Practical sample size calculation for surveillance and diagnostic investigations. J Vet Diagn Investig. 2009;21:3-14.
  • 28. Zhou XH, Obuchowski NA, McClish DK. Statistical Methods in Diagnostic Medicine. In: Statistics Wsipa, ed: Wiley series in probability and statistics; 2002.
  • 29. Khodayari-Rostamabad A, Hasey GM, MacCrimmon DJ, Reilly JP, Bruin Hd. A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy. Clin Neurophysiol. 2010;121:1998-2006.
  • 30. Association AP Diagnostic and statistical manual of mental disorders: DSM-IV-TR®. American Psychiatric Pub; 2000.
  • 31. Polich J, Criado JR. Neuropsychology and neuropharmacology of P3a and P3b. IntJ

Psychophysiol. 2006;60:172-185.

< Prev   CONTENTS   Source   Next >